✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Sumitomo Pharma Co Ltd

Common Name
Sumitomo Pharma
Country
Japan
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3,832
Ticker
4506
Exchange
Japan Exchange Group
Description
Sumitomo Pharma Co., Ltd. is a prominent player in the global biopharmaceutical industry, primarily focused on the development, manufacturing, and marketing of pharmaceuticals. The company engages in ...

Sumitomo Pharma's Board and Committee Meetings Data

Explore Sumitomo Pharma's board and committee governance data, including meeting counts and attendance rates for the board, audit committee, compensation/remuneration committee, and nomination committee.

Metric2026
Board Meeting Count
21a
Audit Committee Meeting Count
13a
Audit Committee Meeting Attendance Rate
100%a
Compensation/Remuneration Committee Meeting Count
8a
Compensation/Remuneration Committee Meeting Attendance Rate
92.59%a
Nomination Committee Meeting Count
8a
Nomination Committee Meeting Attendance Rate
92.59%a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Sumitomo Pharma’s Board and Committee Meetings Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Sumitomo Pharma's Securities Report 2026